'Govt needs to phase out branded drugs to promote generic medications'
Days after PM Modi's announcement, the Medical Council of India (MCI) had directed all the hospitals, doctors and state medical council to prescribe generic medicines to patients.
May 01, 2017, 12:25 PM IST
DNA: MCI cracks the whip on errant hospitals, doctors; directs them to prescribe generic drugs
The implication of this directive is huge as India moves to mitigate healthcare costs across the nation.
Apr 23, 2017, 00:44 AM IST
MCI directs hospitals, doctors across India to prescribe generic medicines to patients
This move comes few days after Prime Minister Narendra Modi urged at bringing a legal framework under which generic medicines should be given by the doctors and the healthcare system in India should have an extensive reach so that drugs are made available to all the people.
Apr 22, 2017, 16:34 PM IST
Generic drugs: Are they as effective as brand-name versions?
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, safety, route of administration, quality, performance, intended use and risks.
Apr 18, 2017, 11:10 AM IST
Modi govt aims to break doctor-pharma company nexus, medicines will become cheaper
We will bring in a legal framework by which if a doctor writes a prescription, he has to write in it that it will be enough for patients to buy generic medicine and he need not buy any other medicine, he said.
Apr 18, 2017, 10:05 AM IST
Germany suspends marketing of 54 drugs tested by India's GVK Bio
Germany has suspended marketing of 54 drugs tested by GVK Biosciences in compliance with the European Union's ban on around 700 generic drugs.
Aug 22, 2015, 11:09 AM IST
EU suspends sale of 700 generic drugs made in India
European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India, the EU`s executive confirmed on Monday.
Jul 27, 2015, 23:55 PM IST
Pharmexcil sees $1.2 billion export hit from EU ban
India's business loss arising from the European Union's ban on 700 generic drugs is likely to be around USD 1.2 billion, says industry body Pharmexcil.
Jul 27, 2015, 18:39 PM IST
Lupin, Cipla bid for UCB's US generic drugs portfolio: Report
Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.
Jun 01, 2015, 18:56 PM IST
Endo to buy Par Pharmaceutical for $8.05 billion
Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo`s generic drugs business, the companies said Monday.
May 18, 2015, 20:48 PM IST
India may take WTO action against EU over drug clinical trials: GVK
The privately-held company, part of India`s infrastructure builder GVK Group, conducts clinical research for domestic and foreign drugmakers.
Apr 16, 2015, 10:40 AM IST
Novartis profits jump 12% on new drug sales
Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.
Jan 27, 2015, 16:17 PM IST
GVK Bio offers to re-do studies after EU ruling
Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.
Dec 08, 2014, 19:49 PM IST
France, Germany suspend some drug approvals over Indian data
All of the drugs being suspended, several of which are manufactured by Mylan Inc and Abbott , have brand name equivalents that can be used instead, so patients will not have to interrupt their treatment.
Dec 06, 2014, 08:48 AM IST
US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs
Drug firm Ranbaxy Laboratories on Wednesday said the DC Federal Court in the US has not granted the company temporary restraining order to block the US health regulator from approving other ANDAs for generic versions of digestive disorder medicine Nexium and anti-viral Valcyte.
Nov 26, 2014, 14:26 PM IST
US denies Ranbaxy's bid to block launch of rival generics
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral, a court filing showed.
Nov 20, 2014, 21:58 PM IST
US court overturns bid by Ranbaxy to block launch of rival generic drugs
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral Valcyte.
Nov 20, 2014, 11:06 AM IST
Indian drugmakers see US sales hit by delay in new approvals
Leading Indian generic drugmakers Dr Reddy`s Laboratories Ltd and Glenmark Pharmaceuticals Ltd this month posted a drop in their second-quarter US sales
Nov 12, 2014, 09:24 AM IST
Lupin launches generic Ciprofloxacin in US market
The company had earlier received final approval for the product from the USFDA.
Jun 13, 2014, 17:17 PM IST
